The Use Of Novel Agents Like TARLATAMAB May Be “ Interesting ” Among Patients With Small_Cell_Lung_Cancer In The Relapsed Setting, Says Gregory Peter Kalemkerian, MD. . #lcsm | @UMRogelCancer .